stavudine (Cipla Ltd.)


Welcome to the PulseAid listing for the stavudine drug offered from Cipla Ltd.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cipla Ltd.
NON-PROPRIETARY NAME: stavudine
SUBSTANCE NAME: STAVUDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-03-20
END MARKETING DATE: 0000-00-00


stavudine HUMAN PRESCRIPTION DRUG Details:

Item Descriptionstavudine from Cipla Ltd.
LABELER NAME: Cipla Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2009-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53104-0111_48215ef9-e91f-42ff-96ab-b4f33a95baf4
PRODUCT NDC: 53104-0111
APPLICATION NUMBER: ANDA078030

Other STAVUDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedStavudine
Camber Pharmaceuticals, Inc.Stavudine
Cipla Ltd.stavudine
Citron Pharma LLCStavudine
E.R. Squibb & Sons, L.L.C.ZERIT
KAISER FOUNDATION HOSPITALSStavudine
Mylan Pharmaceuticals Inc.Stavudine
Rising Pharmaceuticals, Inc.Stavudine
State of Florida DOH Central PharmacyZERIT